
BERLIN (Reuters) -German pharma company Bayer reported positive study results for its anticoagulant asundexian on Sunday, two years after a research setback for the promising blood thinner candidate.
In a Phase III study, a daily dose of 50 milligrams significantly reduced the risk of ischemic stroke compared with a placebo, Bayer said.
Detailed results from the OCEANIC-STROKE study will be presented at an upcoming scientific congress, said Bayer.
Bayer added that it plans to speak with health authorities worldwide in preparation for the submission of marketing authorisation applications.
Bayer had originally predicted that asundexian would have peak sales potential of more than 5 billion euros ($5.76 billion) - more than any of its other drugs.
At the end of 2023, the company had a major setback with the drug after it failed in a pivotal clinical trial involving patients with atrial fibrillation and a risk of stroke.
($1 = 0.8687 euros)
(Reporting by Joern Poltz. Writing by Miranda Murray. Editing by Jane Merriman)
latest_posts
- 1
These men carry towers of birds through Mexico's streets. They say their tradition is dying out. - 2
I'm a woman who's into weightlifting. Was I man enough for the creatine-packed 'Man Cereal'? - 3
How did life begin on Earth? New experiments support 'RNA world' hypothesis - 4
German police 'cleared path for fascists with batons,' protesters say - 5
Lebanese Shi’a party Amal competing, coordinating with Hezbollah, experts tell ‘Post’
More loons are filling Maine's lakes with their ghostlike calls
Songbirds swap colorful plumage genes across species lines among their evolutionary neighbors
The most effective method to Connect Successfully with Teachers in a Web based Setting
Spain’s Picos de Europa: What to see and do in ‘the world’s most beautiful place’
You finally got a doctor's appointment. Here's how to get the most out of it
Nurturing Hacks: Astuteness from Experienced Mothers and Fathers
My daughter is in the #1 movie in the country. She still has to finish her math homework.
Vote In favor of Your #1 Method for diminishing Pressure
Lecturer who called Israel a terrorist state to remain Plaid Cymru candidate













